Product image of Maxitrol (Neomycin Sulfate, Polymyxin B Sulfate, Dexamethasone) supplied by GNH India

Maxitrol

Active Ingredient:
Neomycin Sulfate, Polymyxin B Sulfate, Dexamethasone
Origin:
EU

Maxitrol (Neomycin Sulfate, Polymyxin B Sulfate, Dexamethasone)

Neomycin Sulfate, Polymyxin B Sulfate, Dexamethasone, the active ingredient in Maxitrol, is an antibiotic and corticosteroid combination presented as an ophthalmic suspension for ocular use. It treats bacterial eye infections and inflammation in adults and children as directed by a healthcare professional.

GNH India supplies Maxitrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Novartis S.R.O.,

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Maxitrol is used to manage ocular infections and inflammatory conditions affecting the anterior segment of the eye.

  • Bacterial conjunctivitis: reduces bacterial load and associated inflammation, helping to resolve infection.
  • Keratitis: combats bacterial pathogens on the cornea while decreasing inflammatory swelling.
  • Uveitis: suppresses intra‑ocular inflammation and prevents further tissue damage.
  • Post‑operative ocular inflammation: controls postoperative swelling and prevents secondary infection after eye surgery.

How It Works

  • Neomycin sulfate inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, while polymyxin B sulfate disrupts bacterial cell‑membrane integrity, leading to rapid bacterial death. Dexamethasone, a potent glucocorticoid, binds intracellular glucocorticoid receptors and suppresses multiple inflammatory pathways, reducing cytokine release, vascular permeability, and leukocyte migration in ocular tissues.

Side Effects

Adverse reactions may occur with ocular administration of Maxitrol.

Common Side Effects

  • Stinging or burning sensation upon instillation.
  • Transient eye redness or mild conjunctival hyperemia.
  • Tearing or increased lacrimation.
  • Temporary blurred vision.
  • Mild eye irritation or foreign‑body sensation.

Serious or Rare Side Effects

  • Allergic reactions such as eyelid edema, rash, or anaphylaxis.
  • Corneal ulceration or epithelial defect.
  • Elevated intra‑ocular pressure leading to secondary glaucoma.
  • Severe ocular pain or vision loss.
  • Persistent infection despite therapy.

Precautions & Warnings

Before using Maxitrol, consider the following safety measures.

  • Allergy assessment: avoid if known hypersensitivity to neomycin, polymyxin B, dexamethasone, or any excipients.
  • Contact lens use: remove lenses before instillation and wait at least 15 minutes before reinserting.
  • Systemic absorption: limit duration to prescribed course to reduce systemic corticosteroid exposure.
  • Pregnancy and lactation: use only if the potential benefit outweighs the risk; consult a physician.
  • Monitor intra‑ocular pressure: especially with prolonged dexamethasone use.
  • Store at room temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Maxitrol may interact with other ophthalmic agents.

Major Interactions (Avoid)

  • Systemic corticosteroids: concurrent use may increase systemic glucocorticoid effects.
  • Live vaccines: systemic absorption of dexamethasone could suppress immune response.
  • Anticholinergic eye drops: may reduce the therapeutic effect of Maxitrol.

Moderate Interactions (Monitor Closely)

  • Topical non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of corneal toxicity.
  • Other ophthalmic antibiotics: potential additive ocular irritation.
  • Preservative‑containing contact lens solutions: may heighten local irritation.

Frequently Asked Questions

Maxitrol is prescribed for bacterial eye infections such as conjunctivitis, as well as inflammatory ocular conditions including keratitis, uveitis, and inflammation that can occur after eye surgery. It combines an antibiotic and a corticosteroid to address both infection and inflammation in the same formulation.

Neomycin interferes with bacterial protein synthesis, while polymyxin B damages bacterial cell membranes, together providing broad‑spectrum antibacterial activity. Dexamethasone acts on glucocorticoid receptors to suppress inflammatory mediators, reducing swelling, redness, and pain in the eye.

The specific dose and frequency of Maxitrol are determined by the prescribing clinician based on the severity of the infection or inflammation, the patient’s age, and response to therapy. Patients should follow the exact instructions provided by their healthcare professional.

Safety in pregnancy and lactation has not been fully established. Maxitrol should be used only if the potential benefit justifies any possible risk to the fetus or infant, and this decision should be made in consultation with a qualified healthcare provider.

To request Maxitrol, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with single‑agent eye drops, Maxitrol offers the advantage of simultaneous antibacterial and anti‑inflammatory activity, potentially reducing the need for multiple medications. However, the presence of a corticosteroid requires careful monitoring for side effects such as increased intra‑ocular pressure, which may not be a concern with antibiotics alone.

Store Maxitrol at room temperature, preferably below 25 °C. Keep the bottle tightly closed in its original packaging, protect it from light, and avoid exposure to moisture. Do not freeze the product.

Maxitrol is applied as eye drops. The patient should wash their hands, tilt the head back, pull down the lower eyelid to create a pocket, and instill the prescribed number of drops. The eyes should be closed gently for a few minutes to allow absorption, and contact lenses should be removed before use.

Serious risks include allergic reactions that can cause swelling, rash, or anaphylaxis, as well as ocular complications such as corneal ulceration, elevated intra‑ocular pressure leading to glaucoma, and rare cases of vision loss. Prompt medical attention is required if any severe symptoms develop.

Maxitrol should not be used by individuals with known hypersensitivity to neomycin, polymyxin B, dexamethasone, or any formulation components. It is also contraindicated in patients with viral eye infections such as herpes simplex keratitis, as corticosteroids can exacerbate viral replication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.